Exam 66: Antitubercular Agents

A patient has a Mantoux tuberculin skin test with a 12-mm area of induration.The patient has a cough,and a chest radiograph is positive.The primary care NP should refer this patient to an infectious disease specialist and should plan to monitor a regimen of:

A patient who takes isoniazid and rifampin for latent TB comes to the clinic with a new-onset cough and night sweats.The primary care NP should evaluate these findings by ordering:

A patient receives a Mantoux tuberculin skin test as part of screening for a new job.The test is administered on a Friday,and the patient returns to the clinic the following Wednesday.The primary care nurse practitioner (NP)notes a 3-mm area of induration.The patient has no risk factors for tuberculosis (TB).The NP should:

A patient who has been taking medications to treat TB tells the primary care NP that the infectious disease specialist has added ethambutol to the drug regimen.The patient asks the NP for information about this drug.The NP should explain that this drug:

A patient who is taking isoniazid and rifampin for latent TB is seen by the primary care NP for a routine follow-up visit.The patient reports having nausea,vomiting,and a decreased appetite.The NP should:

A patient is taking isoniazid,pyrazinamide,rifampin,and streptomycin to treat TB.The primary care NP should routinely perform:

A primary care NP sees a 5-year-old child for a tuberculin skin test.The child lives in a high-risk community,and a grandparent who babysits has active TB.The PPD shows a 6-mm area of induration.A chest radiograph is normal.The NP will refer this patient to an infectious disease specialist and should expect the patient to be on _____ for _____ months.

A patient comes to the clinic to have a Mantoux tuberculin skin test read after 48 hours.The primary care NP notes a 6-mm area of induration.The patient is a young adult with no known contacts and has never traveled abroad.The NP should: